Nova Leap Health Gelecekteki Büyüme

Future kriter kontrolleri 0/6

Şu anda Nova Leap Health için büyüme ve gelir tahmini yapmak üzere yeterli analist kapsamımız yok.

Anahtar bilgiler

n/a

Kazanç büyüme oranı

n/a

EPS büyüme oranı

Healthcare kazanç büyümesi	60.7%
Gelir büyüme oranı	n/a
Gelecekteki özkaynak getirisi	n/a
Analist kapsamı	None
Son güncelleme	n/a

Gelecekteki son büyüme güncellemeleri

Güncelleme yok

Recent updates

Nova Leap Health Corp.'s (CVE:NLH) 35% Share Price Surge Not Quite Adding Up

Oct 31

Risks Still Elevated At These Prices As Nova Leap Health Corp. (CVE:NLH) Shares Dive 27%

Sep 12

Nova Leap Health Corp.'s (CVE:NLH) 33% Price Boost Is Out Of Tune With Revenues

Jun 08

Should Shareholders Reconsider Nova Leap Health Corp.'s (CVE:NLH) CEO Compensation Package?

May 31

Bu bölümde, yatırımcıların şirketin kâr elde etme kabiliyetini anlamalarına yardımcı olmak için genellikle profesyonel analistlerin fikir birliği tahminlerine dayanan gelir ve kazanç büyüme tahminlerini sunuyoruz. Ancak Nova Leap Health yeterli geçmiş veri sağlamadığından ve analist tahmini olmadığından, gelecekteki kazançları geçmiş verileri ekstrapole ederek veya analist tahminlerini kullanarak güvenilir bir şekilde hesaplanamaz.

SimplyWall St tarafından kapsanan şirketlerin %97'si geçmiş finansal verilere sahip olduğu için bu oldukça nadir bir durumdur.

Kazanç ve Gelir Büyüme Tahminleri

TSXV:NLH - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (USD Millions )
Tarih	Gelir	Kazançlar	Serbest Nakit Akışı	Faaliyetlerden Nakit	Avg. Analist Sayısı
9/30/2024	26	0	2	2	N/A
6/30/2024	26	0	2	2	N/A
3/31/2024	26	0	2	2	N/A
12/31/2023	26	-1	2	2	N/A
9/30/2023	26	-1	1	1	N/A
6/30/2023	27	-1	2	2	N/A
3/31/2023	27	-1	1	1	N/A
12/31/2022	28	-1	1	1	N/A
9/30/2022	27	-1	2	2	N/A
6/30/2022	25	0	2	2	N/A
3/31/2022	24	0	3	3	N/A
12/31/2021	21	2	2	2	N/A
9/30/2021	20	4	1	1	N/A
6/30/2021	19	3	2	2	N/A
3/31/2021	18	2	3	3	N/A
12/31/2020	17	1	3	3	N/A
9/30/2020	18	0	3	3	N/A
6/30/2020	18	-1	1	1	N/A
3/31/2020	18	0	1	1	N/A
12/31/2019	17	-1	1	1	N/A
9/30/2019	16	-1	0	0	N/A
6/30/2019	15	-1	0	0	N/A
3/31/2019	13	-1	-1	-1	N/A
12/31/2018	10	-1	-2	-2	N/A
9/30/2018	7	-1	-1	-1	N/A
6/30/2018	5	-1	N/A	-1	N/A
3/31/2018	2	-1	N/A	-1	N/A
12/31/2017	1	-1	N/A	-1	N/A
12/31/2016	0	0	N/A	0	N/A
10/31/2016	0	0	N/A	0	N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: NLH 'un tahmini kazanç büyümesinin tasarruf oranının ( 2.3% ) üzerinde olup olmadığını belirlemek için yeterli veri yok.

Kazançlar ve Piyasa: NLH 'un kazançlarının Canadian pazarından daha hızlı büyümesinin öngörülüp öngörülmediğini belirlemek için yeterli veri yok

Yüksek Büyüme Kazançları: NLH şirketinin kazançlarının önümüzdeki 3 yıl içerisinde önemli ölçüde artıp artmayacağını belirlemek için yeterli veri bulunmuyor.

Gelir ve Pazar: NLH şirketinin gelirinin Canadian pazarından daha hızlı büyüyeceğinin tahmin edilip edilmediğini belirlemek için yeterli veri yok.

Yüksek Büyüme Geliri: NLH şirketinin gelirinin yıllık 20% oranından daha hızlı artacağının tahmin edilip edilmediğini belirlemek için yeterli veri yok.

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: NLH 'un Özsermaye Getirisi'nin 3 yıl içinde yüksek olmasının öngörülüp öngörülmediğini belirlemek için yeterli veri yok

Nova Leap Health Gelecekteki Büyüme

Future kriter kontrolleri 0/6

Anahtar bilgiler

Gelecekteki son büyüme güncellemeleri

Recent updates

Third quarter 2024 earnings released: US$0.002 loss per share (vs US$0.004 profit in 3Q 2023)

Nova Leap Health Corp.'s (CVE:NLH) 35% Share Price Surge Not Quite Adding Up

Risks Still Elevated At These Prices As Nova Leap Health Corp. (CVE:NLH) Shares Dive 27%

New minor risk - Share price stability

Second quarter 2024 earnings released: EPS: US$0.003 (vs US$0.002 loss in 2Q 2023)

Nova Leap Health Corp.'s (CVE:NLH) 33% Price Boost Is Out Of Tune With Revenues

Should Shareholders Reconsider Nova Leap Health Corp.'s (CVE:NLH) CEO Compensation Package?

First quarter 2024 earnings released: EPS: US$0.005 (vs US$0.003 loss in 1Q 2023)

Insufficient new directors

Nova Leap Health Corp., Annual General Meeting, Jun 07, 2024

Nova Leap Health Corp. (CVE:NLH) Looks Just Right With A 28% Price Jump

Full year 2023 earnings released

Market Participants Recognise Nova Leap Health Corp.'s (CVE:NLH) Revenues

Second quarter 2023 earnings released: US$0.002 loss per share (vs US$0 in 2Q 2022)

Nova Leap Health Corp. Announces Impairment for the Second Quarter Ended June 30, 2023

Nova Leap Health Corp. to Report Q2, 2023 Results on Aug 10, 2023

Nova Leap Health Corp. Announces Change of Corporate Secretary

Nova Leap Health Corp. (CVE:NLH) Investors Are Less Pessimistic Than Expected

New minor risk - Share price stability

Independent Director recently bought CA$99k worth of stock

First quarter 2023 earnings released: US$0.003 loss per share (vs US$0.005 loss in 1Q 2022)

Full year 2022 earnings released: US$0.01 loss per share (vs US$0.024 profit in FY 2021)

Does Nova Leap Health (CVE:NLH) Have A Healthy Balance Sheet?

Third quarter 2022 earnings released: EPS: US$0.007 (vs US$0.016 in 3Q 2021)

Third quarter 2022 earnings released: EPS: US$0.007 (vs US$0.016 in 3Q 2021)

Now 22% undervalued after recent price drop

Now 27% undervalued after recent price drop

Nova Leap Health Corp. announced that it has received CAD 2.385056 million in funding

Nova Leap Health Corp. announced that it expects to receive CAD 2.5 million in funding

Independent Director recently bought CA$94k worth of stock

Now 23% undervalued after recent price drop

Calculating The Intrinsic Value Of Nova Leap Health Corp. (CVE:NLH)

Second quarter 2022 earnings released: EPS: US$0 (vs US$0.005 in 2Q 2021)

Nova Leap Health (CVE:NLH) Is Carrying A Fair Bit Of Debt

First quarter 2022 earnings released: US$0.005 loss per share (vs US$0.013 profit in 1Q 2021)

Full year 2021 earnings: EPS in line with expectations, revenues disappoint

Nova Leap Health Corp., Annual General Meeting, Apr 21, 2022

Independent Director recently bought CA$99k worth of stock

Nova Leap Health Corp. (TSXV:NLH) completed the acquisition of Home Care Business With Operations Located in Kentucky and Indiana.

Independent Chairman of the Board recently bought CA$53k worth of stock

Third quarter 2021 earnings released: EPS US$0.02 (vs US$0.007 in 3Q 2020)

Estimating The Intrinsic Value Of Nova Leap Health Corp. (CVE:NLH)

Nova Leap Health Corp. (TSXV:NLH) acquired Business assets of a home care services company located in Oklahoma.

Second quarter 2021 earnings released: EPS US$0.01 (vs US$0.012 loss in 2Q 2020)

Independent Director exercised options to buy CA$228k worth of stock.

Nova Leap Health Corp entered into an agreement to acquire Home care services company.

Nova Leap Health Corp. announced that it has received CAD 5.499999 million in funding

Nova Leap Health Corp. announced that it expects to receive CAD 1.999999 million in funding

First quarter 2021 earnings released: EPS US$0.01 (vs US$0.005 in 1Q 2020)

Nova Leap Health Corp. Appoints Marie Mullally to Board of Directors

Nova Leap Health (CVE:NLH) Strong Profits May Be Masking Some Underlying Issues

Full year 2020 earnings released: EPS US$0.02 (vs US$0.017 loss in FY 2019)

Revenue misses expectations

Nova Leap Health Corp., Annual General Meeting, Apr 29, 2021

New 90-day high: CA$0.87

New 90-day high: CA$0.58

Third quarter 2020 earnings released: EPS US$0.01

New 90-day high: CA$0.48

New 90-day high: CA$0.40

New 90-day high - CA$0.38

Earnings released

New 90-day low - CA$0.30

Kazanç ve Gelir Büyüme Tahminleri

Analist Gelecek Büyüme Tahminleri

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Büyüyen şirketleri keşfedin